BERNARDI, GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 158.024
AS - Asia 16.400
EU - Europa 12.673
SA - Sud America 1.998
AF - Africa 154
Continente sconosciuto - Info sul continente non disponibili 59
OC - Oceania 28
AN - Antartide 1
Totale 189.337
Nazione #
US - Stati Uniti d'America 157.678
SG - Singapore 8.872
CN - Cina 3.197
UA - Ucraina 2.426
DE - Germania 2.144
RU - Federazione Russa 1.666
BR - Brasile 1.656
HK - Hong Kong 1.491
IE - Irlanda 1.293
IT - Italia 1.041
FR - Francia 1.037
VN - Vietnam 960
SE - Svezia 762
GB - Regno Unito 632
PL - Polonia 626
FI - Finlandia 596
KR - Corea 479
BD - Bangladesh 369
JP - Giappone 353
CA - Canada 175
IN - India 158
AR - Argentina 133
NL - Olanda 100
MX - Messico 82
BE - Belgio 71
ID - Indonesia 68
ES - Italia 59
IQ - Iraq 56
TR - Turchia 55
EC - Ecuador 51
EU - Europa 51
ZA - Sudafrica 50
AT - Austria 45
VE - Venezuela 35
UZ - Uzbekistan 34
KG - Kirghizistan 33
PK - Pakistan 33
CL - Cile 32
CO - Colombia 30
CZ - Repubblica Ceca 29
MA - Marocco 28
AU - Australia 25
SA - Arabia Saudita 25
AE - Emirati Arabi Uniti 22
MY - Malesia 22
PY - Paraguay 22
PH - Filippine 21
IL - Israele 20
RO - Romania 19
CH - Svizzera 18
EG - Egitto 18
LT - Lituania 18
UY - Uruguay 16
KE - Kenya 15
PE - Perù 15
TN - Tunisia 15
JM - Giamaica 14
NP - Nepal 14
HN - Honduras 13
IR - Iran 13
JO - Giordania 13
TT - Trinidad e Tobago 13
CR - Costa Rica 12
AZ - Azerbaigian 11
GR - Grecia 11
KZ - Kazakistan 11
PT - Portogallo 11
AL - Albania 10
BG - Bulgaria 10
GE - Georgia 10
OM - Oman 10
DM - Dominica 9
TH - Thailandia 9
DK - Danimarca 8
DZ - Algeria 8
NI - Nicaragua 8
BH - Bahrain 6
LB - Libano 6
LV - Lettonia 6
RS - Serbia 6
DO - Repubblica Dominicana 5
HR - Croazia 5
MT - Malta 5
NG - Nigeria 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BO - Bolivia 4
CI - Costa d'Avorio 4
GT - Guatemala 4
KH - Cambogia 4
SV - El Salvador 4
CG - Congo 3
GY - Guiana 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
PS - Palestinian Territory 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
Totale 189.294
Città #
Woodbridge 49.573
Wilmington 39.409
Houston 36.530
Fairfield 4.888
Ann Arbor 4.138
Singapore 3.373
Ashburn 2.537
Jacksonville 2.244
Seattle 1.981
Cambridge 1.614
Hong Kong 1.476
San Jose 1.460
Chandler 1.394
Dublin 1.291
Beijing 1.053
Medford 976
Dearborn 601
Santa Clara 594
Kraków 576
The Dalles 532
New York 501
Lawrence 465
Zhengzhou 368
Los Angeles 356
Mülheim 349
Ho Chi Minh City 309
Buffalo 285
Tokyo 276
Moscow 268
Hangzhou 264
San Diego 238
Hanoi 225
Menlo Park 223
Rome 193
Council Bluffs 189
Lauterbourg 167
Milan 160
Dallas 154
São Paulo 143
Falls Church 131
Munich 115
Helsinki 109
University Park 103
Mountain View 100
London 97
Shanghai 97
San Mateo 96
Chicago 95
Verona 90
Norwalk 84
Orem 82
Detroit 80
Guangzhou 78
Hefei 74
Redwood City 71
Boardman 66
Mcallen 64
Brussels 58
Palo Alto 58
Nanjing 55
Brooklyn 54
Rio de Janeiro 54
Montreal 51
Toronto 49
Redondo Beach 48
Saint Petersburg 48
Chennai 47
Atlanta 41
Nuremberg 40
Phoenix 40
Brasília 39
Frankfurt am Main 39
Haiphong 38
Warsaw 38
Da Nang 37
Dhaka 36
Nürnberg 36
San Francisco 35
Stockholm 35
Denver 34
Kunming 34
Columbus 33
Belo Horizonte 32
Jakarta 31
Johannesburg 31
Porto Alegre 30
Boston 29
Amsterdam 28
North Bergen 28
Naples 27
Campinas 25
Mexico City 24
Brno 23
Manchester 23
Tashkent 23
Curitiba 22
Jinan 22
Biên Hòa 21
St Louis 21
Turku 21
Totale 164.543
Nome #
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression 726
Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia 617
The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis 616
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis 608
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis. 606
TRPV1 channels facilitate glutamate transmission in the striatum 599
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 595
Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition 580
Rasagiline effect on bladder disturbances in early mild Parkinson's disease patients 571
Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the 'indirect pathway' 567
Spastic paraplegia, epilepsy, and mental retardation in several members of a family: a novel genetic disorder 560
Reduced GABA Content in the Motor Thalamus during effective deep brain stimulation of the subthalamic nucleus 557
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 551
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 549
The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients 543
Leukocyte aggregation in patients with a previous cerebral ischemic event 529
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 528
Neuroacanthocytosis associated with a defect of the 4.1R membrane protein 521
Connectivity Between Posterior Parietal Cortex and Ipsilateral Motor Cortex Is Altered in Schizophrenia 518
Down-regulation of nitrergic transmission in the rat striatum after chronic nigrostriatal deafferentation 518
Adjuvant pneumomediastinum in thoracoscopic thymectomy for myasthenia gravis 513
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA 513
Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot-Marie-Tooth disease type 1A 510
A continuous high frequency stimulation of the subthalamic nucleus determines a suppression of excitatory synaptic transmission in nigral dopaminergic neurons recorded in vitro 510
Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine 508
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism 507
Spontaneous sleep modulates the firing pattern of Parkinsonian subthalamic nucleus 507
The myotonic dystrophy type 2 (DM2) gene product zinc finger protein 9 (ZNF9) is associated with sarcomeres and normally localized in DM2 patients' muscles 501
Altered long-term corticostriatal synaptic plasticity in transgenic mice overexpressing human CU/ZN superoxide dismutase (GLY(93)-->ALA) mutation 501
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 497
Subacute demyelinating polyneuropathy in B-cell lymphoma with IgM antibodies against glycolipid GD1b 497
AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis 495
Clinical and genetic study of a large SPG4 Italian family 494
Video-assisted completion thymectomy in refractory myasthenia gravis 492
Manganese intoxication decreases the expression of manganoproteins in the rat basal ganglia: an immunohistochemical study. 492
Inhibition of persistent sodium current fraction and voltage-gated L-type calcium current by propofol in cortical neurons: Implications for its antiepileptic activity 490
Differences in the neurotoxicity profile induced by ATP and ATPgammaS in cultured cerebellar granule neurons 490
TRPV1 channels regulate cortical excitability in humans 489
The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie 489
Serial determinations of leukocyte aggregation in patients with ischemic stroke 487
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors 485
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 485
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus. 484
Age-related functional changes of high-voltage-activated calcium channels in different neuronal subtypes of mouse striatum 484
Cortical hyperexcitability in post-traumatic stress disorder secondary to minor accidental head trauma: a neurophysiologic study 484
Up-regulation of P2X(2), P2X(4) receptor and ischemic cell death: Prevention by P2 antagonists 483
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 481
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 481
Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment 478
Abnormal activity of the Na/Ca exchanger enhances glutamate transmission in experimental autoimmune encephalomyelitis 478
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 477
Differential distribution of nicotinamide adenine dinucleotide phosphate-diaphorase and neural nitric oxide synthase in the rat choroid plexus. A histochemical and immunocytochemical study 474
Muscarinic IPSPs in rat striatal cholinergic interneurones 474
Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum 474
Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease 471
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis 470
Role of the metabotropic P2Y(4) receptor during hypoglycemia: cross talk with the ionotropic NMDAR1 receptor 470
P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat 470
Curariform peripheral block of muscular tone selectively increases precentral N30 somatosensory evoked potentials component. A pharmacological study carried out on healthy subjects and parkinsonian syndromes 470
Thoracoscopic thymectomy in autoimmune myasthenia: Results of left-sided approach 469
Left thoracoscopic approach to the thymus in myasthenic patients 469
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 469
Increased levels of p70S6 phosphorylation in the G93A mouse model of Amyotrophic Lateral Sclerosis and in valine-exposed cortical neurons in culture 469
Hippocampus versus entorhinal cortex decoupling by an NR2 subunit-specific block of NMDA receptors in a rat in vitro model of temporal lobe epilepsy 469
Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans 468
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 468
Synaptic transmission in the striatum: from plasticity to neurodegeneration 468
Resistance to striatal dopamine depletion induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice expressing human mutant Cu,Zn superoxide dismutase 468
Difficulty diagnosing chronic cryptococcal meningitis in idiopathic CD4+ lymphocytopenia 467
Sural nerve without nerve fibers in leprous neuropathy 467
SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status 467
The effect of levodopa therapy on dopamine transporter SPECT imaging with 123I-FP-CIT in patients with Parkinson's disease 466
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 466
Microdialysis in Parkinsonian patient basal ganglia: acute apomorphine-induced clinical and electrophysiological effects not paralleled by changes in the release of neuroactive amino acids 466
Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum 465
Distinct roles of group I mGlu receptors in striatal function 465
Distinguishing forms of generalized epilepsy using magnetic brain stimulation 464
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 464
Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum 464
Serial determinations of leukocyte aggregation in patients with ischemic stroke 464
The Project for a Scientific Psychology (1895): a Freudian anticipation of LTP-memory connection theory 463
Sub-cellular localization of manganese in the basal ganglia of normal and manganese-treated rats An electron spectroscopy imaging and electron energy-loss spectroscopy study. 463
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid. 462
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis 462
Cerebrospinal fluid levels of Aβ42 relationship with cholinergic cortical activity in Alzheimer's disease patients 462
PDE10A and PDE10A-dependent cAMP catabolism are dysregulated oppositely in striatum and nucleus accumbens after lesion of midbrain dopamine neurons in rat: a key step in parkinsonism physiopathology 462
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 461
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. 461
Altered vulnerability to kainate excitotoxicity of transgenic-Cu/Zn SOD1 neurones 460
Early subclinical cochlear dysfunction in myotonic dystrophy type 1. 460
The Blockade of K+-ATP channels has neuroprotective effects in an in vitro model of brain ischemia 460
Transcranial magnetic stimulation primes the effects of exercise therapy in multiple sclerosis 459
Migraine-like disorder segregating with mtDNA 14484 Leber hereditary optic neuropathy mutation 459
Video-assisted complete thymectomy in the treatment of autoimmune myasthenia [Timectomia estesa video-assistita nel trattamento della miastenia autoimmune] 458
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 458
Neurophysiology of Parkinson's disease: from basic research to clinical correlates 458
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 457
Dystrophin is not essential for the integrity of the cytoskeleton 457
GABAergic signaling and connectivity on Purkinje cells are impaired in experimental autoimmune encephalomyelitis 457
Hypoglycaemia-induced cell death: features of neuroprotection by the P2 receptor antagonist basilen blue 456
Totale 49.511
Categoria #
all - tutte 395.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 395.452


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.433 134 476 189 251 139 549 213 193 287 475 192 1.335
2022/20234.612 564 284 99 497 322 1.282 418 218 354 13 454 107
2023/20241.293 140 45 109 27 113 378 60 89 19 17 13 283
2024/202511.886 306 2.422 1.129 530 216 654 669 365 824 611 2.365 1.795
2025/202614.588 1.121 827 1.796 1.135 1.220 517 1.572 1.968 1.671 1.481 698 582
2026/202712 12 0 0 0 0 0 0 0 0 0 0 0
Totale 189.991